Navigation Links
Death from heart attack can be reduced by new drug combination

Heart attack remains one of the significant causes for mortality in more than 10 million people all over the world. It accounts for 29.2 percent of total global deaths according to the World Health Organization.// People who survive the episode require long-term care and support. Amongst the risk factors, the important ones are obesity, smoking, diabetes, high blood pressure and high cholesterol.

A majority of the deaths can now be prevented by a combination of aspirin and another drug Clopidogrel. The drug combination has been found to be very effective in preventing the clot formation in such patients.

Aspirin is a standard emergency treatment given to heart attack patients and the proposed drug (Clopidogrel) is the world's fourth biggest-selling drug. If the clopidogrel therapy was instituted to just 1 million people then more than 10000 deaths, non-fatal repeat heart attacks and stroke could be prevented.

The efficacy of the drug has been studied in a group of 45,800 patients against a placebo and patients who received 75 milligrams of the drug daily, in addition to an aspirin or other treatment for 4 weeks, had a 7 % and 14 % reduction in death rate and repeat heart attack rate respectively.

The researchers also found that using the blood pressure drug metoprolol intravenously and then orally as an emergency treatment for heart attacks reduced the relative risk of a repeat attack but raised the odds of cardiac shock, especially in the first day or so after being admitted to hospital.

The drug is complementary to aspirin but works in a different way. Only about two weeks of treatment with the drug would be needed so the costs would be small. The safety and the efficacy of the drug have also been satisfactory. Hence it has been suggested that the drug be used routinely on top of aspirin to produce a moderate yet significant health benefit in the emergency treatment of heart attack.


'"/>




Page: 1

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology: